Recall
FDAHealthApril 10, 2026

Medline Industries, LP — Medline kits containing Huons Co. Bupivacaine HCL in Dextrose Injection, USP, labeled as: SPINAL BLOCK 22G QUINCKE 5S BU, Medline Kit SKU DYNJRA9026

⚠️ Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
April 10, 2026

Worldwide - US Nationwide distribution in the US Territory of Virgin Islands and the countries of Bahamas, Panama, Barbados.

What's affected?

Product
Medline kits containing Huons Co. Bupivacaine HCL in Dextrose Injection, USP, labeled as: SPINAL BLOCK 22G QUINCKE 5S BU, Medline Kit SKU DYNJRA9026
Lot code
26BBD235

Additional details

Medline Kit SKU DYNJRA9026: UDI/DI 10884389285688 each, 40884389285689, case, Lot Numbers: 26BBD235, 26ABB534, 25DBT837, 25CBH118, 24FBT403, 24FBJ505.

What should I do?

Recommended action

Class I recall. Voluntary: Firm initiated Quantity affected: 4370 kits.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.